Related Experiment Video
Updated: Jul 15, 2026
08:01
Oct4GiP Reporter Assay to Study Genes that Regulate Mouse Embryonic Stem Cell Maintenance and Self-renewal
Published on: May 30, 2012
New and renewed perspectives on embryonic stem cell pluripotency
Jackson A Hoffman1, Bradley J Merrill
1Department of Biochemistry and Molecular Genetics, University of Illinois at Chicago, Chicago, IL 60607, USA.
Summary
Stem cell biology research has a unique history, with recent advances in understanding pluripotency in embryonic stem cells (ESC) offering new therapeutic opportunities. This review contextualizes these discoveries within historical knowledge of embryonic development and lineage commitment.
Area of Science:
- Stem cell biology
- Developmental biology
- Epigenetics
Background:
- The study of pluripotency in embryonic cells has a complex history, gaining prominence with mouse embryonic stem cells (ESC) and later human ESC lines.
- Understanding the genetic and epigenetic regulation of pluripotency is crucial for advancing cell-based therapies and understanding cancer stem cells.
- Historical knowledge of pluripotency and lineage commitment in embryonic development provides essential context for recent discoveries.
Purpose of the Study:
- To review recent discoveries in ESC pluripotency.
- To contextualize new findings within the historical understanding of pluripotency and lineage commitment.
- To elucidate the importance and limitations of current research and identify future research directions.
Main Methods:
- Literature review focusing on historical and recent research in stem cell biology.
- Analysis of genetic and epigenetic mechanisms regulating pluripotency in ESC.
- Integration of findings from the pre-bioinformatics/genomics era with contemporary data.
Main Results:
- Recent advances have significantly deepened the understanding of the genetic and epigenetic regulation of ESC pluripotency.
- The historical perspective reveals a gradual evolution in the study of pluripotency, from early observations to sophisticated molecular analyses.
- New discoveries offer potential for novel cell-based therapies and a better understanding of disease mechanisms involving cancer stem cells.
Conclusions:
- Understanding the historical context of pluripotency research is vital for appreciating recent breakthroughs in ESC biology.
- Continued investigation into the genetic and epigenetic regulation of pluripotency holds significant promise for regenerative medicine and disease research.
- Future research should focus on integrating historical knowledge with modern genomic and bioinformatic approaches to fully elucidate pluripotency mechanisms.
More Related Videos
09:07Chemical Reversion of Conventional Human Pluripotent Stem Cells to a Naïve-like State with Improved Multilineage Differentiation Potency
Published on: June 10, 2018
07:18A Simple Method to Identify Kinases That Regulate Embryonic Stem Cell Pluripotency by High-throughput Inhibitor Screening
Published on: May 12, 2017
Related Concept Videos
01:14Maintenance of the ES Cell State
The cells of the blastocyst inner cell mass only remain pluripotent for a short time. This state of pluripotency and self-renewal can be maintained in embryonic stem (ES) cell culture by adding specific chemicals or growth factors to ensure the cells can continue dividing and later differentiate into different cell types. In some cases, the cells are grown on a feeder layer of differentiated cells, which provides the growth factors and extracellular matrix components necessary for stem cell...
01:29Somatic to iPS Cell Reprogramming
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012 for this...
01:13Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
01:06Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Somatic cells are...
01:13Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
00:58Embryonic Stem Cells
Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.